Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the ...

The treatment itself is highly targeted because the atoms of dye bind to the receptors on cancer cells while leaving healthy ...

The Yukon chapter of Ride for Dad drew 221 motorcyclists for a roughly 211-kilometre journey along the Alaska Highway, ...

Researchers are studying axolotls -- "small, smiling salamanders" -- in the hopes of learning how humans might one day regrow ...

The multimodal ArteraAI Prostate Test combines digital images of patients' biopsies and clinical data to predict prognoses and treatment outcomes.

Instead of homing in on PSMA—currently the most validated target in prostate cancer—BMS and Philochem will instead ...

The FDA has approved Nubeqa (darolutamide), an androgen receptor inhibitor, for the treatment of mCSPC in adults.

BMS entered the radiopharma space via its $4.1 billion buyout of RayzeBio at the end of 2023. Unlike Novartis’ approved ...

For all men, but particularly for men that are older, we’re very, very much supporting screening for prostate cancer.” ...

Ben Stiller, David Bowie and Alan Rickman are among the celebrities who chose to battle their diagnosis in private.

Dr. Samir Taneja joins Northwell Health to lead urology, focusing on prostate cancer, robotic surgery and innovative ...